Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting on Diabetic Retinal Disease (DRD)

Thursday, February 12, 10:00am - 3:00pm (EST)

Join the Mary Tyler Moore Vision Initiative for a landmark national event where the voices of those impacted by diabetic retinal disease (DRD) will take center stage. This FDA-recognized Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting is your opportunity to directly inform the future of DRD treatments and research by sharing your story, insights, and needs with regulators, drug developers, doctors, and the broader public.

Patients, caregivers, and community members will have the chance to:

Speak directly to the FDA and industry leaders,
Participate in live discussions, call-ins, and polls,
Submit comments before, during, and after the meeting,
Hear testimonials and panel discussions from real patients and caregivers.

Whether you join as an active participant or audience member, your voice will help shape tomorrow’s care for diabetic retinal disease. Make an impact, connect with others, and advocate for meaningful change.

Your experience matters—step forward and help build a brighter future for DRD care!

To find out more or get involved, visit: https://www.marytylermoore.org/el-pfdd or contact us at MTMVisionDRD-PFDDinfo@umich.edu.

Time shown in-05:00America, New York

Link:

Thursday, February 12, 10:00am - 3:00pm (EST)

Please fill out the information below to register for the event.

Goingdone
Interestedstar_border
Not goingclear

Name

Location (City/State or Country)

How would you like to identify yourself for this event?

Confirmed

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Add to Calendar2026/02/12 10:00:002026/02/12 15:00:00America/DetroitExternally-Led Patient-Focused Drug Development (EL-PFDD) Meeting on Diabetic Retinal Disease (DRD)Join the Mary Tyler Moore Vision Initiative for a landmark national event where the voices of those impacted by diabetic retinal disease (DRD) will take center stage. This FDA-recognized Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting is your opportunity to directly inform the future of DRD treatments and research by sharing your story, insights, and needs with regulators, drug developers, doctors, and the broader public.

Patients, caregivers, and community members will have the chance to:

Speak directly to the FDA and industry leaders,
Participate in live discussions, call-ins, and polls,
Submit comments before, during, and after the meeting,
Hear testimonials and panel discussions from real patients and caregivers.

Confirmed

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Speak directly to the FDA and industry leaders,
Participate in live discussions, call-ins, and polls,
Submit comments before, during, and after the meeting,
Hear testimonials and panel discussions from real patients and caregivers.

Thank you!

Your changes have been saved. Thanks for keeping us updated.

https://www.marytylermoore.org/el-pfdd/live

MTM Vision, MTMVisionDRD-PFDDinfo@umich.edu